Want to see SE:ERMA full AI Analyst Report?
Enorama Pharma AB (ERMA) Income Statement
Enorama Pharma AB Income Statement
Last quarter (Q2 2026), Enorama Pharma AB's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Enorama Pharma AB's net income was $-13.12M. See Enorama Pharma AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.74M | $ 15.77M | $ 1.36M | $ 6.85M | $ 11.04M | |
| $ -61.78M | $ 3.70M | $ -3.90M | $ -616.00K | $ 2.13M | |
| $ 339.00K | $ 51.22M | $ 38.23M | $ 41.35M | $ 29.07M | |
| Depreciation and Amortization | $ 469.00K | $ 20.41M | $ 3.55M | $ 3.54M | $ 1.38M |
| $ -61.65M | $ -20.41M | $ -40.18M | $ -37.22M | $ -25.56M | |
| $ -62.12M | $ -47.52M | $ -41.84M | $ -41.47M | $ -26.94M | |
| $ -13.02M | $ 3.71M | $ -2.77M | $ -560.00K | $ -802.00K | |
| $ -75.14M | $ -43.81M | $ -44.61M | $ -42.03M | $ -27.74M | |
| $ -75.14M | $ -43.81M | $ -44.61M | $ -41.78M | $ -28.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.08 | $ -0.83 | $ -1.61 | $ -4.40 | $ -3.80 |
| Diluted EPS | $ -1.08 | $ -0.83 | $ -1.61 | $ -4.40 | $ -3.80 |
| Weighted Average Shares Outstanding | 69.48M | 53.04M | 27.70M | 9.49M | 7.52M |
| Weighted Average Shares Outstanding (Diluted) | 69.48M | 53.04M | 27.70M | 9.49M | 7.52M |
Currency in SEK